Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130565) titled 'Pan-Amyloid PET/CT in Various Amyloid-Related Disease' on Aug. 12.

Study Type: Observational [Patient Registry]

Primary Sponsor: Tianjin Medical University

Condition: Amyloid Cardiac Amyloidosis Amyloidosis

Intervention: Diagnostic Test: 18F-92/AV45/TPZA/FT8, 11CPIB

Recruitment Status: Recruiting

Date of First Enrollment: November 1, 2023

Target Sample Size: 500

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130565

Published by HT Digital Content Services with permission from Health Daily Digest....